Business Context and Reporting Period
Kochav Defense Acquisition Corp. (KCHV) is a Cayman Islands exempted company formed as a Special Purpose Acquisition Company (SPAC). The company was incorporated on January 7, 2025, and consummated its Initial Public Offering (IPO) on May 29, 2025. The reporting period covers the fiscal year ended December 31, 2025. The company has no operating history and has generated no operating revenues to date. Its primary objective is to effect a Business Combination with one or more businesses, with a specific focus on the defense and aerospace industries.
Key Financial Metrics
| Metric | Value (as of Dec 31, 2025) |
|---|---|
| Trust Account Balance | $259,039,708 |
| Redemption Price per Public Share | ~$10.24 |
| Cash Outside Trust Account | $709,887 |
| Net Income (Inception to Dec 31, 2025) | $5,535,163 |
| General & Administrative Costs | $523,430 |
| Deferred Underwriting Fee | $6,957,500 |
| Working Capital Surplus | $694,188 |
Capital Structure: As of March 30, 2026, there were 25,824,050 Class A Ordinary Shares and 8,433,333 Class B Ordinary Shares (Founder Shares) outstanding. The company holds 25,300,000 Public Shares subject to possible redemption.
Material Changes and Operational Status
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a "going concern" due to the requirement to complete a Business Combination by November 29, 2026 (or May 29, 2027 if extended), or liquidate.
- Revenue Generation: The company has generated no operating revenue. Net income is derived entirely from interest and dividends earned on investments held in the Trust Account ($6,039,708) and operating account interest ($18,885).
- Trust Account Growth: The Trust Account balance increased from the initial $253,000,000 deposit to $259,039,708 due to interest income earned during the period.
- Related Party Transactions: The company pays its Sponsor $22,900 per month for administrative services. As of year-end, $160,300 was incurred, with $114,500 paid and $45,800 accrued.
Guidance, Outlook, and Risks
Outlook and Timeline: The company must consummate an initial Business Combination by November 29, 2026 (18 months from IPO). The Sponsor may extend this period twice by three months each (totaling 24 months) without shareholder approval, or seek shareholder approval for further extensions. If no combination is completed, the company will liquidate and redeem Public Shares at the pro rata Trust Account balance.
Management Commentary: Management intends to use substantially all funds in the Trust Account to complete a Business Combination. They are actively searching for targets in the defense and aerospace sectors but have not selected a specific target as of the filing date.
Key Risks:
- Liquidity: The company relies on the Sponsor for working capital loans (up to $1.5 million convertible) to fund operations if cash outside the Trust Account is insufficient.
- Geopolitical Instability: Conflicts in Ukraine, the Middle East, and between the U.S., Israel, and Iran may disrupt capital markets and affect target business operations.
- Redemption Risk: Significant redemptions by Public Shareholders could reduce the cash available for a transaction, potentially requiring additional financing.
- Investment Company Act: To avoid classification as an investment company, the company may liquidate Trust Account investments into cash or demand deposits, potentially reducing interest income.
Investor Verification Checklist
- Extension Mechanics: Verify the specific terms and shareholder approval thresholds required to extend the Combination Period beyond the initial 18-month deadline.
- Trust Account Composition: Confirm the current asset allocation within the Trust Account (e.g., money market funds vs. cash) to assess interest rate sensitivity.
- Working Capital Adequacy: Assess the sufficiency of the ~$710,000 cash balance outside the Trust Account to fund operations through the end of the Combination Period without additional Sponsor loans.
- Deferred Fee Impact: Note that the $6,957,500 deferred underwriting fee is payable only upon a successful Business Combination and will reduce net proceeds available to the combined entity.
- Founder Share Dilution: Review the anti-dilution provisions for Class B Founder Shares, which may convert at a ratio greater than 1:1 if significant equity is issued to consummate a transaction.